Modulation of angiogenesis in a model of chronic inflammation.
Jackson
J R
JR
Department of Immunopharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA. Jeffrey_R_Jackson@sbphrd.com
Bolognese
B
B
Kircher
C H
CH
Marshall
L A
LA
Winkler
J D
JD
D000388:Air; D000818:Animals; D003436:Croton Oil; D004195:Disease Models, Animal; D005260:Female; D006099:Granuloma / Q000209:etiology / Q000503:physiopathology*; D007375:Interleukin-1 / Q000378:metabolism; D008525:Medroxyprogesterone / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011479:Protamines / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D007375:Interleukin-1; D011479:Protamines; D014409:Tumor Necrosis Factor-alpha; D003436:Croton Oil; D008525:Medroxyprogesterone